Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02028884
Brief Title: Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

First Submitted : January 6, 2014
First Submitted that Met QC Criteria : January 6, 2014
First Posted : January 7, 2014 (Estimate)

Certification/Extension First Submitted : June 5, 2019
Certification/Extension First Submitted that Met QC Criteria : June 5, 2019
Certification/Extension First Posted : June 7, 2019

Last Update Submitted that Met QC Criteria : December 18, 2019
Last Update Posted : December 20, 2019